HS
JNCE

HighVista Strategies’s Jounce Therapeutics, Inc. Common Stock JNCE Stock Holding History

HighVista Strategies’s Portfolio JNCE Stock Details JNCE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-15,000
Closed -$104K – 138
2020
Q2 		$104K Buy
15,000
+4,300
+40% +$29.8K 0.09% 76
2020
Q1 		$51K Hold
10,700
– – 0.05% 43
2019
Q4 		$93K Sell
10,700
-7,600
-42% -$66.1K 0.07% 81
2019
Q3 		$61K Buy
+18,300
New +$61K 0.04% 106